The kinase targets in non-small cell lung cancer (NSCLC) include epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK) and ROS proto-oncogene 1 (ROS1) (Korpanty et al., 2014). This evidence concerns the gene ROS1 and non-small cell lung carcinoma.